Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...

Medtronic will act as the exclusive sales agent of MagnetOsTM for USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to sell, market and ...

In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.

Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sel ...

Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.

From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Enveric Biosciences, Inc. has announced that it will release an Investor Presentation on its website on or about January 3, 2025. This presentation will be used by the company to engage with ...

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid ...

Founded in 2020, Genflow Biosciences Plc. (LSE:GENF)(OTCQB:GENFF), a biotechnology company headquartered in the UK with R&D facilities in Belgium, is pioneering gene therapies to decelerate the aging ...